Literature DB >> 26922718

Long-Term Cigarette Smoking Trajectories Among HIV-Seropositive and Seronegative MSM in the Multicenter AIDS Cohort Study.

Wajiha Z Akhtar-Khaleel1, Robert L Cook2, Steve Shoptaw3, Pamela J Surkan4, Linda A Teplin5, Ronald Stall6, Rebecca J Beyth7,8, Todd M Manini2,9, Michael Plankey10.   

Abstract

To examine the association between demographic characteristics and long-term smoking trajectory group membership among HIV-seropositive and HIV-seronegative men who have sex with men (MSM). A cohort of 6552 MSM from the Multicenter AIDS Cohort Study were asked detailed information about their smoking history since their last follow-up. Group-based trajectory modeling was used to examine smoking behavior and identify trajectory group membership. Because participants enrolled after 2001 were more likely to be younger, HIV-seronegative, non-Hispanic black, and have a high school diploma or less, we also assessed time of enrollment in our analysis. Participants were grouped into 4 distinct smoking trajectory groups: persistent nonsmoker (n = 3737 [55.9 %]), persistent light smoker (n = 663 [11.0 %]), heavy smoker to nonsmoker (n = 531 [10.0 %]), and persistent heavy smoker (n = 1604 [23.1 %]). Compared with persistent nonsmokers, persistent heavy smokers were associated with being enrolled in 2001 and later (adjusted odds ratio [aOR] 2.35; 95 % CI 2.12-2.58), having a high school diploma or less (aOR 3.22; 95 % CI 3.05-3.39), and being HIV-seropositive (aOR 1.17; 95 % CI 1.01-1.34). These associations were statistically significant across all trajectory groups for time of enrollment and education but not for HIV serostatus. The overall decrease of smoking as shown by our trajectory groups is consistent with the national trend. Characteristics associated with smoking group trajectory membership should be considered in the development of targeted smoking cessation interventions among MSM and people living with HIV.

Entities:  

Keywords:  MACS; PLWH; Smoking; Trajectories

Mesh:

Year:  2016        PMID: 26922718      PMCID: PMC4945456          DOI: 10.1007/s10461-016-1343-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  32 in total

1.  Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Authors:  Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

Review 2.  Adolescent resilience: a framework for understanding healthy development in the face of risk.

Authors:  Stevenson Fergus; Marc A Zimmerman
Journal:  Annu Rev Public Health       Date:  2005       Impact factor: 21.981

3.  Adolescent smoking trajectories: results from a population-based cohort study.

Authors:  Debra H Bernat; Darin J Erickson; Rachel Widome; Cheryl L Perry; Jean L Forster
Journal:  J Adolesc Health       Date:  2008-05-29       Impact factor: 5.012

4.  Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals.

Authors:  Lauren R Pacek; Paul T Harrell; Silvia S Martins
Journal:  Am J Addict       Date:  2014-07-25

5.  Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance-using MSM.

Authors:  Steven P Kurtz; Mance E Buttram; Hilary L Surratt; Ronald D Stall
Journal:  AIDS Educ Prev       Date:  2012-06

6.  Impact of cigarette smoking on mortality in HIV-positive and HIV-negative veterans.

Authors:  Kristina Crothers; Joseph L Goulet; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Matthew Bidwell Goetz; Stephen Crystal; David A Leaf; Adeel A Butt; R Scott Braithwaite; Robin Peck; Amy C Justice
Journal:  AIDS Educ Prev       Date:  2009-06

7.  Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.

Authors:  James M Tesoriero; Susan M Gieryic; Alvaro Carrascal; Howard E Lavigne
Journal:  AIDS Behav       Date:  2010-08

8.  HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study.

Authors:  R A Royce; W Winkelstein
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

9.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

10.  Current cigarette smoking among adults - United States, 2005-2012.

Authors:  Israel T Agaku; Brian A King; Shanta R Dube
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-01-17       Impact factor: 17.586

View more
  15 in total

Review 1.  Mechanisms Underlying HIV-Associated Noninfectious Lung Disease.

Authors:  Rachel M Presti; Sonia C Flores; Brent E Palmer; Jeffrey J Atkinson; Catherine R Lesko; Bryan Lau; Andrew P Fontenot; Jesse Roman; John F McDyer; Homer L Twigg
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

2.  Drinking and smoking patterns during pregnancy: Development of group-based trajectories in the Safe Passage Study.

Authors:  Kimberly Dukes; Tara Tripp; Marian Willinger; Hein Odendaal; Amy J Elliott; Hannah C Kinney; Fay Robinson; Julie M Petersen; Cheryl Raffo; Dale Hereld; Coen Groenewald; Jyoti Angal; Gary Hankins; Larry Burd; William P Fifer; Michael M Myers; Howard J Hoffman; Lisa Sullivan
Journal:  Alcohol       Date:  2017-06-15       Impact factor: 2.405

3.  Trajectories of Marijuana Use among HIV-seropositive and HIV-seronegative MSM in the Multicenter AIDS Cohort Study (MACS), 1984-2013.

Authors:  Chukwuemeka N Okafor; Robert L Cook; Xinguang Chen; Pamela J Surkan; James T Becker; Steve Shoptaw; Eileen Martin; Michael W Plankey
Journal:  AIDS Behav       Date:  2017-04

Review 4.  Lung cancer in persons with HIV.

Authors:  Keith Sigel; Alain Makinson; Jonathan Thaler
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

5.  Changes in smoking status among a longitudinal cohort of gay, bisexual, and other men who have sex with men in Vancouver, Canada.

Authors:  Helia Shariati; Heather L Armstrong; Zishan Cui; Nathan J Lachowsky; Julia Zhu; Praney Anand; Eric A Roth; Robert S Hogg; Greg Oudman; Christina Tonella; David M Moore
Journal:  Drug Alcohol Depend       Date:  2017-08-16       Impact factor: 4.492

6.  Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.

Authors:  Rebecca L Ashare; Morgan Thompson; Katrina Serrano; Frank Leone; David Metzger; Ian Frank; Robert Gross; Anita Hole; Karam Mounzer; Ronald G Collman; E Paul Wileyto; Robert Schnoll
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

7.  Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits.

Authors:  Hua-Jun Liang; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  AIDS       Date:  2022-03-15       Impact factor: 4.177

8.  Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.

Authors:  Paul Leger; Sanika Chirwa; Megan Turner; Danielle M Richardson; Paxton Baker; Michael Leonard; Husamettin Erdem; Lana Olson; David W Haas
Journal:  Pharmacogenet Genomics       Date:  2016-10       Impact factor: 2.089

9.  Beyond experimentation: Five trajectories of cigarette smoking in a longitudinal sample of youth.

Authors:  Lauren M Dutra; Stanton A Glantz; Nadra E Lisha; Anna V Song
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

10.  Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

Authors:  Aysel Gueler; André Moser; Alexandra Calmy; Huldrych F Günthard; Enos Bernasconi; Hansjakob Furrer; Christoph A Fux; Manuel Battegay; Matthias Cavassini; Pietro Vernazza; Marcel Zwahlen; Matthias Egger
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.